Source BioScience PLC Holding(s) in Company (4784F)
12 Novembre 2015 - 11:18AM
UK Regulatory
TIDMSBS
RNS Number : 4784F
Source BioScience PLC
12 November 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i)
1. Identity of the issuer SOURCE BIOSCIENCE PLC
or the underlying issuer
of existing shares to which
voting rights are attached:
(ii)
----------------------------- ----------------------
2 Reason for the notification (please tick the
appropriate box or boxes):
----------------------------------------------------
An acquisition or disposal of voting rights YES
---------------------------------------------- ----
An acquisition or disposal of qualifying
financial instruments which may result in
the acquisition of shares already issued
to which voting rights are attached
---------------------------------------------- ----
An acquisition or disposal of instruments
with similar economic effect to qualifying
financial instruments
---------------------------------------------- ----
An event changing the breakdown of voting
rights
---------------------------------------------- ----
Other (please
specify):
-------------------------------------------- ----
3. Full name of person(s)
subject to the notification Harwood Capital LLP
obligation: (iii) (as investment adviser/manager)
and North Atlantic
Smaller Companies Investment
Trust plc
--------------------------------- ----------------------------------
4. Full name of shareholder(s)
(if different from 3.): 1. NORTH ATLANTIC SMALLER
(iv) COMPANIES INVESTMENT
TRUST PLC
2. ORYX INTERNATIONAL
GROWTH FUND LIMITED
--------------------------------- ----------------------------------
5. Date of the transaction 6 NOVEMBER 2015
and date on which the threshold
is crossed or reached: (v)
--------------------------------- ----------------------------------
6. Date on which issuer 10 NOVEMBER 2015
notified:
--------------------------------- ----------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) Total Holding through
17%
--------------------------------- ----------------------------------
8. Notified details:
-----------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
-----------------------------------------------------------------------------------------------------------
Class/type Situation Resulting situation after
of previous the triggering transaction
shares to the triggering
transaction
if possible
using
the ISIN
CODE
-------------- ---------------------------- -------------------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights (x)
Shares Voting shares rights
Rights
-------------- ------------- ------------- ------------- ------------------------ --------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------- ------------- ------------- ------------- --------- --------- ---------
HOLDER
1
7,650,000 7,650,000 11,500,000 11,500,000 3.29%
HOLDER
2 50,000,000 50,000,000 50,000,000 50,000,000 14.32%
-------------- ------------- ------------- ------------- ------------- --------- --------- ---------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of % of voting
instrument date Conversion voting rights
(xiii) Period rights that
(xiv) may be
acquired
if the
instrument
is
exercised/
converted.
------------------ ----------- ------------ ------------- ------------
C: Financial Instruments with similar economic
effect to Qualifying Financial Instruments (xv,
xvi)
----------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of % of voting
financial price date Conversion voting rights (xix,
instrument (xvii) period rights xx)
(xviii) instrument
refers
to
------------ --------- ----------- ------------ ------------ ----------------
Nominal Delta
------------ --------- ----------- ------------ ------------ -------- ------
Total (A+B+C)
-----------------------------------------------
Number of voting rights Percentage of voting
rights
------------------------ ---------------------
61,500,000 17.61%
------------------------ ---------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
------------------------------------------------------------
Proxy Voting:
--------------------------------
10. Name of the proxy holder:
------------------------------
11. Number of voting rights
proxy holder will cease
to hold:
------------------------------
12. Date on which proxy
holder will cease to hold
voting rights:
------------------------------
13. Additional information:
------------------------------- --------------
14. Contact name: Jane Muir
------------------------------- --------------
15. Contact telephone number: 020 8819 6486
------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGGQGGUPAGUP
(END) Dow Jones Newswires
November 12, 2015 05:18 ET (10:18 GMT)
Medical Solutions (LSE:MLS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Medical Solutions (LSE:MLS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Medical Solutn (London Stock Exchange): 0 recent articles
Plus d'articles sur Medical Solutn